About US
Contact us
-
Investigational treatment shows promise against Marfan syndromeAn investigational treatment for Marfan syndrome is as effective as the standard therapy at slowing enlargement of the aorta, the large artery of the heart that delivers blood to the body, new researc2014/11/20
-
PHE survey reveals widespread misconceptions about antibiotics use in UKResearch carried out by Public Health England (PHE) for European Antibiotic Awareness Day (EAAD) revealed widespread misconceptions about the use of antibiotics by the public. Approximately 1,625 adu2014/11/20
-
Cirrus Pharmaceuticals to Invest in cGMP Manufacturing Suite in USCirrus Pharmaceuticals has announced it will be investing in a flexible current good manufacturing practice (cGMP) suite in its facility in Research Triangle Park (RTP), North Carolina. Kemwell presi2014/11/20
-
Actavis signs agreement to buy Botox-maker Allergan for $66bnIreland-based pharmaceutical company Actavis has signed an agreement to acquire US-based Botox-maker Allergan for $66bn or $219 per share. As part of the deal, Allergan will receive a combination of2014/11/19
-
UK grants new funding for five Ebola research projects in West AfricaThe UK Department for International Development (DFID) and the Wellcome Trust are providing £1.34m from a joint fund for five research projects, to combat the Ebola outbreak in West Africa. The2014/11/19
-
Generic Industry Appears Positioned to Sue FDA Over Generic CBE RulePharmaceutical Development Group(PDG™), a pharmaceutical consultant, has published achronology of eventsrelating to FDA's proposed rule that would allow generics to use the CBE process to update2014/11/19
-
BMS's sponsored programme selects four research projects to investigate viral diseasesBristol-Myers Squibb's (BMS) European medical education programme Partnering for Cure has selected four research projects, designed to investigate new ways to cure viral diseases. BMS will provide €32014/11/18
-
AstraZeneca and Isis Pharmaceuticals partner for target oligonucleotides delivery methodsBritish-Swedish drugmaker AstraZeneca has partnered with US-based Isis Pharmaceuticals to develop new delivery methods for antisense oligonucleotides. According to Isis, new methods are being develop2014/11/18
-
GSK launches first call for proposals for NCDs research in AfricaGlaxoSmithKline (GSK) has launched the first call for proposals for its Africa NCD Open Lab to support scientific research into non-communicable diseases (NCDs) in Africa. In sub-Saharan Africa and a2014/11/17
-
GSK seeks European approval for eltrombopag to treat severe aplastic anaemiaBritish drug-maker GlaxoSmithKline (GSK) has submitted a marketing authorisation application to the European Medicines Agency (EMA) seeking an additional indication for eltrombopag (Revolade). The ap2014/11/14